AssetMark Inc
IMNM icon

AssetMark Inc’s Immunome IMNM Stock Holding History

AssetMark Inc’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$130K Buy
6,063
+992
+20% +$24.6K ﹤0.01% 1577
2026
Q2 		$107K Buy
5,071
+536
+12% +$11.5K ﹤0.01% 1605
2026
Q1 		$99.2K Buy
4,535
+1,442
+47% +$32.1K ﹤0.01% 1543
2025
Q4 		$66.4K Sell
3,093
-271
-8% -$4.76K ﹤0.01% 1618
2025
Q3 		$39.4K Buy
+3,364
New +$33.5K ﹤0.01% 1713

Other funds holding IMNM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

AssetMark Inc's IMNM Position: Q3 2026 in Review

AssetMark Inc increased its Immunome (IMNM) stake by 20% in Q3 2026, buying an estimated $24.6K and bringing the position to 6,063 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

AssetMark Inc first reported a position in IMNM in Q3 2025 and has held it in 5 quarters since. 65 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • AssetMark Inc held 6,063 shares of Immunome worth $130K as of Q3 2026.
  • AssetMark Inc bought 992 Immunome shares in Q3 2026, an estimated $24.6K.
  • Immunome made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1577 holding.
  • AssetMark Inc first reported a position in Immunome in Q3 2025 and has held it in 5 quarters since.
  • 65 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.